arrow
S

Sang Won Seo

Sungkyunkwan University School of Medicine
H指数:48
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasma eMTBR-tau243 and p-tau205 as T2 biomarkers for biological staging and prognosis in Alzheimer’s disease

血浆eMTBR-tau243和p-tau205作为阿尔茨海默病生物分期和预后的T2生物标志物

2026-10-190
OAAI
A centiloid-scaled crossover of amyloid and tau influences on plasma p-Tau217 along the Alzheimer’s disease continuum

阿尔茨海默病连续谱中,以百分之一洛德为单位计的淀粉样蛋白和tau蛋白影响对血浆p-Tau217的交叉影响

2026-09-290
OAAI
APOE ‐guided lecanemab dosing dissociates ARIA‐E from ARIA‐H: The K‐ROAD study

APOE指导下的利卡奈姆剂量分离ARIA-E与ARIA-H:K-ROAD研究

2026-08-250
OAAI
Cellular Senescence of Patient-derived Fibroblasts Reveals the Mid-old Stage as a Critical Window for Transcriptomic Signatures Linked to Alzheimer's Disease Biomarkers and Classification

患者来源成纤维细胞的细胞衰老揭示了中年阶段作为与阿尔茨海默病生物标志物和分类相关的转录组特征的关键窗口

2026-05-010
PRE
Biomarker-integrated prognostic stagings for Alzheimer’s Disease

阿尔茨海默病的生物标志物综合预后分期

2026-02-020
OAAI
Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use

血浆pTau217的双重截止策略,以预测跨多个测定平台的Tau PET阳性: Tau富集和Tau稀缺的队列,以实现具有成本效益的临床使用

2026-01-140
OAAI
Sex, education and race/ethnicity have distinct effects on amyloid and tau‐PET status

性别、教育程度和种族/族裔对淀粉样蛋白和tau-PET状态具有不同的影响

2026-01-080
OAAI
CT-derived brain volumes and plasma p-Tau217 for risk stratification of amyloid positivity in early-stage Alzheimer’s disease

CT衍生的脑容积和血浆p-Tau217用于早期阿尔茨海默病中淀粉样蛋白阳性的风险分层

2025-10-300
OAAI
Age-related amyloid beta dynamics modeled with the generalized additive model for location, scale, and shape (GAMLSS) across diverse populations: Cross-sectional trajectories and longitudinal validation

基于位置-尺度-形状广义加性模型(GAMLSS)对多人群年龄相关淀粉样蛋白β动力学进行建模:横断面轨迹与纵向验证

2025-09-100
OAAI
EBP1 potentiates amyloid β pathology by regulating γ-secretase

EBP1通过调节γ-分泌酶增强淀粉样β病理学

2025-01-080
PRE